Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
REVIEW ARTICLE  

 Article Access Statistics
    Viewed2104    
    Printed64    
    Emailed0    
    PDF Downloaded187    
    Comments [Add]    
    Cited by others 3    

Recommend this journal


Click on image for details.

 Troponin elevations in patients with chronic cardiovascular disease: An analysis of current evidence and significance

Archer K Martin1, Anita K Malhotra2, Breandan L Sullivan3, Harish Ramakrishna4
1 Department of Anesthesiology, Mayo Clinic Florida, FL, USA
2 Department of Anesthesiology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
3 Department of Anesthesiology and Critical Care Medicine, University of Colorado Hospital, Aurora, CO, USA
4 Division of Cardiovascular and Thoracic Anesthesiology, Mayo Clinic Arizona, AZ, USA

Correspondence Address:
Harish Ramakrishna
Department of Anesthesiology, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.179638

Rights and Permissions

Year : 2016  |  Volume : 19  |  Issue : 2  |  Page : 321-327

 
SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (387 KB)
Email article
Print Article
Add to My List
Serum troponin elevation above the 99th percentile of the upper reference limit in healthy subjects (<0.01 ng/ml measured using currently available high-sensitivity cardiac troponin laboratory assays) is required to establish the diagnosis the diagnosis of myocardial necrosis in acute cardiovascular syndromes, as well as guide prognosis and therapy. In the perioperative period, for patients with cardiac disease undergoing noncardiac surgery, it is a particularly critical biomarker universally used to assess the myocardial damage. The value of troponin testing and elevation (as well as its significance) in patients with chronic cardiac valvular, vascular, and renal disease is relatively less well understood. This evidence-based review seeks to examine the currently available data assessing the significance of troponin elevation in certain chronic valvular and other disease states.






[FULL TEXT] [PDF]*
 

 

  Sitemap | Feedback | Disclaimer | Privacy Notice | What's New  
  © Annals of Cardiac Anaesthesia | Published by Wolters Kluwer - Medknow
 Online since 5th January, 2008

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 REVIEW ARTICLE
 



Archer K Martin1, Anita K Malhotra2, Breandan L Sullivan3, Harish Ramakrishna4
1 Department of Anesthesiology, Mayo Clinic Florida, FL, USA
2 Department of Anesthesiology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
3 Department of Anesthesiology and Critical Care Medicine, University of Colorado Hospital, Aurora, CO, USA
4 Division of Cardiovascular and Thoracic Anesthesiology, Mayo Clinic Arizona, AZ, USA

Correspondence Address:
Harish Ramakrishna
Department of Anesthesiology, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.179638

Rights and Permissions

Serum troponin elevation above the 99th percentile of the upper reference limit in healthy subjects (<0.01 ng/ml measured using currently available high-sensitivity cardiac troponin laboratory assays) is required to establish the diagnosis the diagnosis of myocardial necrosis in acute cardiovascular syndromes, as well as guide prognosis and therapy. In the perioperative period, for patients with cardiac disease undergoing noncardiac surgery, it is a particularly critical biomarker universally used to assess the myocardial damage. The value of troponin testing and elevation (as well as its significance) in patients with chronic cardiac valvular, vascular, and renal disease is relatively less well understood. This evidence-based review seeks to examine the currently available data assessing the significance of troponin elevation in certain chronic valvular and other disease states.






[FULL TEXT] [PDF]*


        
Print this article     Email this article  

  Sitemap | Feedback | Disclaimer | Privacy Notice | What's New  
  © Annals of Cardiac Anaesthesia | Published by Wolters Kluwer - Medknow
 Online since 5th January, 2008